USD10
KROS Ações
Sobre Keros TherapeuticsKeros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
USD10
KROS Ações
Sobre Keros TherapeuticsKeros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
Estatísticas
JANELA DE NEGOCIAÇÃO
Fechado
ABRE ÀS
1 de abr. at 13:30 GMT+0
CAPITALIZAÇÃO DE MERCADO
US$ 336,35 mi
PREÇO ABERTO
Sem dados suficientes
BAIXO (1 A)
US$ 9,12
ALTO (1 A)
US$ 22,55
BAIXO (24H)
US$ 10,89
ALTO (24H)
US$ 11,48
VOLUME (24H)
US$ 267,29 mil
30,85%
Histórico de preços
Time | Price | Change |
|---|---|---|
Hoje | Sem dados suficientes | Sem dados suficientes |
1 dia | US$ 10,90 | |
1 semana | US$ 11,25 | |
1 mês | US$ 14,16 | |
1 ano | US$ 10,04 |